Proud contributor to public health
Navamedic is a nordic pharma company and a reliable supplier of high-quality products.
29.06.2025
Navamedic ASA – Additional underwriting commitments in the Rights Issue
27.06.2025
Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product
24.06.2025
Navamedic ASA – Investor presentation regarding the acquisition of the business of dne pharma AS
-
Employees
43
-
Revenue 2024 (MNOK)
531.4
-
EBITDA 2024 (MNOK)
46.6
-
Number of products
84
-
Countries where products are sold
13
-
Established in
2002
Financial Results
Take part of up-to-date financial results in our quarterly webcasts and reports.
View results
New treatment for erectile dysfunction
Navamedic is now launching Eroxon® across pharmacies in Denmark. Eroxon® will be the first clinically proven over-the-counter topical treatment for the treatment of erectile dysfunction in men in Denmark.
Learn more